The results confirmed that LINC01018 overexpression not only inhibited the growth of glioma cells but also downregulated miR‐942‐5p expression and upregulated KNG1 expression, while LINC01018 knockdown and miR‐942‐5p mimic did the opposite. The gene discussed is LINC01018; the disease is central nervous system cancer.